#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Kearns-Sayre syndrome Osteosarcoma metastatic Retinopathy proliferative Hidradenitis Adrenogenital syndrome Noonan syndrome Chronic hepatitis B Malignant oligodendroglioma Erythema Idiopathic inflammatory myopathy Guillain-Barre syndrome Malignant melanoma Mantle cell lymphoma recurrent Renal cancer metastatic Cluster headache More trials…

    Learn about Rare Diseases

    Bronchiolitis obliterans syndrome – Basic Information Hereditary angioedema with C1 esterase inhibitor deficiency – Diagnostics Alagille syndrome Ewing’s sarcoma – Treatment Stevens-Johnson syndrome – Treatment Osteosarcoma – Diagnostics Chondrosarcoma – Trials in Disease Synovial sarcoma recurrent – Trials in Disease Wiskott-Aldrich syndrome – Diagnostics Gaucher’s disease type III – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Clebopride Hydrogen Maleate Pramlintide Acetate Methadone Hydrochloride Ammonium Chloride Azelastine Esomeprazole Magnesium Carbetocin Alpha-Tocopherol Obicetrapib Laronidase Sirolimus Nefopam Hydrochloride Temocillin Sodium SAR443820 Dnth103 Tolvaptan Mometasone Furoate Omp12 Cyclophosphamide Monohydrate Keto-Valine Calcium More therapies…

    Learn about Your Condition

    Von Hippel-Lindau disease Delirium Intervertebral disc protrusion Anal incontinence Dry eye Muscle spasticity Type 1 diabetes mellitus Glanzmann's disease Choroid melanoma Bladder cancer stage III Torticollis Myeloid leukaemia Endotracheal intubation Lip and/or oral cavity cancer Cholecystitis acute More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on the Long-Term Safety and Effectiveness of Vosoritide for Children with Achondroplasia

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Osteochondrodysplasia
    Investigated Drugs:
    • Vosoritide
    Germany Spain

  • Study on the Effectiveness and Safety of Eneboparatide, Calcitriol, and Calcium Carbonate for Patients with Chronic Hypoparathyroidism

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Hypoparathyroidism
    Investigated Drugs:
    • [Ala1,3,12,Gln10,Arg11,Trp14]Pth(1-14)/[Ala18,22, Lys26]Pthrp(15-36)Cooh
    • Alfacalcidol
    • Calcitriol
    Belgium Denmark France Germany Hungary Italy +4

  • Efficacy and Safety Evaluation of Tulisokibart in Moderate to Severe Hidradenitis Suppurativa: A Phase 2b Randomized, Double-Blind, Placebo-Controlled Trial

    Not recruiting

    4 1
    Investigated Drugs:
    • Tulisokibart
    France Germany Italy The Netherlands Spain

  • A study to test if tibulizumab works and is safe for adults with systemic sclerosis

    Not recruiting

    2 1
    Hungary Poland Romania Spain

  • A Study of Cagrilintide and Semaglutide for Weight Loss in People with Type 2 Diabetes and Overweight or Obesity

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Overweight
    • Obesity
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Cagrilintide
    • Semaglutide
    Austria Germany Hungary Ireland Poland

  • Study of AMG 732 injection compared to placebo in patients with moderate to severe thyroid eye disease

    Not recruiting

    2 1
    Investigated Drugs:
    • AMG 732
    France Germany Greece Italy Poland Spain
Previous Page
1 … 1,659 1,660 1,661 1,662 1,663 … 1,673
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!